Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma

This study is ongoing, but not recruiting participants.

Study NCT00410462 Information provided by National Cancer Institute (NCI)

First Received: December 11, 2006 Last Updated: October 8, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given